Simplification to dual therapy (atazanavir/ritonavirâ+âlamivudine) versus standard triple therapy [atazanavir/ritonavirâ+âtwo nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

Perez-Molina, J A; Rubio, R; Rivero, A; Pasquau, J; Suárez-Lozano, I; Riera, M; Estébanez, M; Palacios, R; Sanz-Moreno, J; Troya, J; Mariño, A; Antela, A; Navarro, J; Esteban, H; Moreno, S

Simplification to dual therapy (atazanavir/ritonavirâ+âlamivudine) versus standard triple therapy [atazanavir/ritonavirâ+âtwo nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study).

Perez-Molina, J A; Rubio, R; Rivero, A; Pasquau, J; Suárez-Lozano, I; Riera, M; Estébanez, M; Palacios, R; Sanz-Moreno, J; Troya, J; Mariño, A; Antela, A; Navarro, J; Esteban, H; Moreno, S.

Afiliação

Perez-Molina JA; Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain jperezm@salud.madrid.org.
Rubio R; HIV Unit, Hospital Universitario Doce de Octubre, i+12, Madrid, Spain.
Rivero A; Infectious Diseases Unit, Hospital Universitario Reina Sofia/IMIBIC, Córdoba, Spain.
Pasquau J; Infectious Diseases Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Suárez-Lozano I; Infectious Diseases Department, Hospital Infanta Elena, Huelva, Spain.
Riera M; Infectious Diseases Department, Hospital Universitario Son Espases, Mallorca, Spain.
Estébanez M; Infectious Diseases Department, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.
Palacios R; Infectious Diseases Unit, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Sanz-Moreno J; Internal Medicine Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Troya J; Internal Medicine Department, Hospital Universitario Infanta Leonor, Madrid, Spain.
Mariño A; HIV Unit, Hospital Arquitecto Marcide, Ferrol, Spain.
Antela A; Infectious Diseases Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Navarro J; Infectious Diseases Department, Hospital Universitario Vall d'Hebrón, Barcelona, Spain.
Esteban H; Fundación SEIMC-GeSIDA, Madrid, Spain.
Moreno S; Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

J Antimicrob Chemother ; 72(1): 246-253, 2017 01.

Article em En | MEDLINE | ID: mdl-27629070

Assuntos

Fármacos Anti-HIV/uso terapêutico; Terapia Antirretroviral de Alta Atividade/métodos; Quimioterapia de Manutenção/métodos; Adulto; Idoso; Idoso de 80 Anos ou mais; Fármacos Anti-HIV/efeitos adversos; Terapia Antirretroviral de Alta Atividade/efeitos adversos; Feminino; Humanos; Quimioterapia de Manutenção/efeitos adversos; Masculino; Pessoa de Meia-Idade; Resultado do Tratamento; Carga Viral; Adulto Jovem

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Terapia Antirretroviral de Alta Atividade / Quimioterapia de Manutenção Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links